Stock Market Reviews

Read and share opinions on TARS (Tarsus Pharmaceuticals, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock ma

Latest News

• Tarsus Pharmaceuticals (TARS): Losses Widen Despite Strong Growth Outlook, Challenging Bullish Narratives
  Nov 6, 2025
• Tarsus to Participate in Upcoming Investor Conference
  Nov 5, 2025
• Tarsus Pharmaceuticals Inc (TARS) Q3 2025 Earnings Call Highlights: Record Sales and Strategic ...
  Nov 5, 2025
• Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Beats Revenue Estimates
  Nov 4, 2025
• Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements
  Nov 4, 2025
• Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
  Oct 28, 2025
• Why Tarsus Pharmaceuticals (TARS) Is Up 21.6% After Xdemvy’s Uptake and New Trial Announcements—And What's Next
  Oct 8, 2025
• Tarsus Pharmaceuticals (TARS) Moves 10.9% Higher: Will This Strength Last?
  Oct 6, 2025
• Tarsus to Participate in Upcoming Investor Conferences
  Aug 27, 2025
• Analyst Estimates: Here's What Brokers Think Of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) After Its Second-Quarter Report
  Aug 9, 2025
• Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
  Aug 6, 2025
• Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements
  Aug 6, 2025
• Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
  Jul 30, 2025
• Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Path To Profitability
  Jul 24, 2025
• Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
  May 14, 2025
• Tarsus Pharmaceuticals, Inc. (TARS): Among the Best Breakout Stocks to Buy According to Analysts
  May 5, 2025
• Analysts Just Made A Substantial Upgrade To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Forecasts
  May 4, 2025